• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌栓素a - 4类似物作为抗癌剂。

Combretastatin a-4 analogs as anticancer agents.

作者信息

Chaudhary Anurag, Pandeya S N, Kumar P, Sharma P P, Gupta S, Soni N, Verma K K, Bhardwaj G

机构信息

Dr. K.N. Modi Institute of Pharmaceutical Education and Research, Modinagar-201201, U.P., India.

出版信息

Mini Rev Med Chem. 2007 Dec;7(12):1186-205. doi: 10.2174/138955707782795647.

DOI:10.2174/138955707782795647
PMID:18220974
Abstract

Combretastatin A-4 (CA-4) is one of the most potent antimitotic and antiangiogenic agents of natural origin. It has displayed potent antitumor effect in a wide variety of preclinical tumor models. Till date various CA-4 analogs have been synthesized and evaluated for anticancer activity. This review is an attempt to compile the medicinal chemistry of various synthesized CA-4 analogs.

摘要

康普瑞他汀A-4(CA-4)是最有效的天然来源抗有丝分裂和抗血管生成药物之一。它在多种临床前肿瘤模型中显示出强大的抗肿瘤作用。迄今为止,已经合成了各种CA-4类似物并对其抗癌活性进行了评估。这篇综述旨在汇编各种合成的CA-4类似物的药物化学。

相似文献

1
Combretastatin a-4 analogs as anticancer agents.癌栓素a - 4类似物作为抗癌剂。
Mini Rev Med Chem. 2007 Dec;7(12):1186-205. doi: 10.2174/138955707782795647.
2
2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.2-氨基和2'-氨基康普他汀衍生物作为强效抗有丝分裂剂
J Med Chem. 2006 Oct 19;49(21):6412-5. doi: 10.1021/jm060616k.
3
Combretastatin A-4 analogues as antimitotic antitumor agents.作为抗有丝分裂抗肿瘤药物的康普瑞他汀A-4类似物。
Curr Med Chem. 2003 Sep;10(17):1697-722. doi: 10.2174/0929867033457151.
4
Design of combretastatin A-4 analogs as tubulin targeted vascular disrupting agent with special emphasis on their cis-restricted isomers.设计作为微管靶向的新型血管破坏剂的 combretastatin A-4 类似物,特别关注其顺式受限异构体。
Curr Pharm Des. 2013;19(10):1923-55. doi: 10.2174/1381612811319100013.
5
Synthesis and biological activity of pyrrole analogues of combretastatin A-4.康普他汀A-4的吡咯类似物的合成及生物活性
Bioorg Med Chem Lett. 2016 Jul 1;26(13):3001-3005. doi: 10.1016/j.bmcl.2016.05.026. Epub 2016 May 10.
6
Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.新型康普瑞汀 A-4 硫代衍生物的设计、合成及作为微管靶向剂的生物评价。
Eur J Med Chem. 2018 Jan 20;144:797-816. doi: 10.1016/j.ejmech.2017.11.050. Epub 2017 Dec 12.
7
Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog.通过康普瑞汀A-4类似物的反式-顺式异构化实现的光开关抗癌活性。
Org Biomol Chem. 2016 Jan 7;14(1):40-9. doi: 10.1039/c5ob02005k. Epub 2015 Oct 27.
8
Synthesis and Biological Evaluations of 1,2-Diaryl Pyrroles as Analogues of Combretastatin A-4.作为康普他汀A-4类似物的1,2-二芳基吡咯的合成及生物学评价
Chem Biol Drug Des. 2015 Dec;86(6):1541-7. doi: 10.1111/cbdd.12617. Epub 2015 Sep 25.
9
Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents.作为潜在抗癌剂的海因桥连柯里拉京A-4类似物的设计、合成及生物学评价
Bioorg Med Chem. 2017 Dec 15;25(24):6623-6634. doi: 10.1016/j.bmc.2017.10.045. Epub 2017 Nov 1.
10
Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.含硅的微管蛋白聚合抑制剂的设计与合成:用硅连接子取代康普瑞汀 A-4 中的乙烯基部分。
Bioorg Med Chem. 2013 Dec 1;21(23):7381-91. doi: 10.1016/j.bmc.2013.09.046. Epub 2013 Oct 1.

引用本文的文献

1
First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumors.口服生物可利用的血管破坏剂DX1002用于晚期实体瘤患者的首次人体1期研究。
Cell Rep Med. 2025 Feb 18;6(2):101969. doi: 10.1016/j.xcrm.2025.101969.
2
ZLM-7 Blocks Breast Cancer Progression by Inhibiting MDM2 via Upregulation of 14-3-3 Sigma.ZLM-7通过上调14-3-3西格玛抑制MDM2来阻断乳腺癌进展。
Pharmaceuticals (Basel). 2022 Jul 15;15(7):874. doi: 10.3390/ph15070874.
3
Molecular dynamics simulations, docking and MMGBSA studies of newly designed peptide-conjugated glucosyloxy stilbene derivatives with tumor cell receptors.
新型肽缀合葡萄糖氧基二苯乙烯衍生物与肿瘤细胞受体的分子动力学模拟、对接和 MMGBSA 研究。
Mol Divers. 2022 Oct;26(5):2717-2743. doi: 10.1007/s11030-021-10354-9. Epub 2022 Jan 17.
4
Design, Synthesis, and Antipoliferative Activities of Novel Substituted Imidazole-Thione Linked Benzotriazole Derivatives.新型取代咪唑-硫酮连接苯并三唑衍生物的设计、合成及抗增殖活性。
Molecules. 2021 Oct 2;26(19):5983. doi: 10.3390/molecules26195983.
5
β-Carboline-based molecular hybrids as anticancer agents: a brief sketch.基于β-咔啉的分子杂化物作为抗癌剂:简要概述。
RSC Med Chem. 2021 Mar 24;12(5):730-750. doi: 10.1039/d0md00422g. eCollection 2021 May 26.
6
Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy.微管去稳定磺胺类药物作为紫杉烷类化疗的替代药物。
Int J Mol Sci. 2021 Feb 14;22(4):1907. doi: 10.3390/ijms22041907.
7
Synthesis, biological evaluation, and modeling studies of 1,3-disubstituted cyclobutane-containing analogs of combretastatin A4.1,3 - 二取代含环丁烷的康普瑞他汀A4类似物的合成、生物学评价及建模研究
J Mol Struct. 2020 Jun 15;1210. doi: 10.1016/j.molstruc.2020.128025. Epub 2020 May 10.
8
Synthesis and Evaluations of "1,4-Triazolyl Combretacoumarins" and Desmethoxy Analogues.“1,4-三唑基柯里拉京香豆素”及其去甲氧基类似物的合成与评价
European J Org Chem. 2019 Sep 8;2019(33):5610-5623. doi: 10.1002/ejoc.201900569. Epub 2019 Aug 7.
9
3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells.3-乙烯基氮杂环丁烷-2-酮:在MCF-7和MDA-MB-231乳腺癌细胞中的合成、抗增殖及微管蛋白去稳定化活性
Pharmaceuticals (Basel). 2019 Apr 11;12(2):56. doi: 10.3390/ph12020056.
10
Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents.基于康普他汀的衍生物和前药作为抗有丝分裂剂的最新进展。
Medchemcomm. 2017 Jul 4;8(8):1592-1603. doi: 10.1039/c7md00227k. eCollection 2017 Aug 1.